series-a
Stage
1
Investors
About
SynCardia Systems develops and manufactures the SynCardia Total Artificial Heart, a medical device used as a life-saving treatment option for patients with end-stage biventricular heart failure awaiting cardiac transplant.
Explore SynCardia Systems's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.